Implementation of the Hospitalist System and In-Hospital Mortality Among Patients With Cancer: Using the National Health Insurance Cohort Data

IF 3.1 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2025-10-02 DOI:10.1002/cam4.71207
Yun Seo Jang, Il Yun, Yu Shin Park, Eun-Cheol Park, Jaeyong Shin
{"title":"Implementation of the Hospitalist System and In-Hospital Mortality Among Patients With Cancer: Using the National Health Insurance Cohort Data","authors":"Yun Seo Jang,&nbsp;Il Yun,&nbsp;Yu Shin Park,&nbsp;Eun-Cheol Park,&nbsp;Jaeyong Shin","doi":"10.1002/cam4.71207","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Hospitalists are directly responsible for inpatients, from hospitalization to discharge. Recently, Korea has started reimbursing hospitalist inpatient services. However, evidence of hospitalists being associated with improved healthcare quality is lacking. We investigated the association between the hospitalist system and reduced in-hospital mortality among patients with cancer.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This national population-based retrospective cohort study included 398,732 patients with cancer from tertiary and general hospitals with hospitalists whose data were extracted from the Korean National Health Insurance Service Cohort Database in 2021. In-hospital mortality data was obtained, defined as the presence of a record of death between admission and discharge. To increase comparability, we performed a 1:3 propensity score matching based on sex, age, hospital type, hospital region, Charlson Comorbidity Index (CCI), and primary cancer type. We used generalized estimation equation models to estimate the adjusted odds ratios (OR) for in-hospital mortality.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Patients under the hospitalist system had a lower risk of in-hospital mortality (OR: 0.91; 95% CI: 0.87–0.96). Specifically, patients in their 80s (OR = 0.31; 95% confidence interval [CI]: 0.19–0.52) and those with high CCI (OR = 0.93; 95% CI: 0.87–0.99) had a more significant association with lower in-hospital mortality.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Hospitalist services are associated with reduced in-hospital mortality rates in cancer patients, which may be influenced by continuous patient management and expertise. Our results highlight the need for dedicated personnel stationed in hospital wards for improved outcomes of patients with cancer. Our results may encourage the government to consider the expansion of the current policies for efficient allocation of healthcare resources among hospitals in Korea.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 19","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71207","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71207","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Hospitalists are directly responsible for inpatients, from hospitalization to discharge. Recently, Korea has started reimbursing hospitalist inpatient services. However, evidence of hospitalists being associated with improved healthcare quality is lacking. We investigated the association between the hospitalist system and reduced in-hospital mortality among patients with cancer.

Methods

This national population-based retrospective cohort study included 398,732 patients with cancer from tertiary and general hospitals with hospitalists whose data were extracted from the Korean National Health Insurance Service Cohort Database in 2021. In-hospital mortality data was obtained, defined as the presence of a record of death between admission and discharge. To increase comparability, we performed a 1:3 propensity score matching based on sex, age, hospital type, hospital region, Charlson Comorbidity Index (CCI), and primary cancer type. We used generalized estimation equation models to estimate the adjusted odds ratios (OR) for in-hospital mortality.

Results

Patients under the hospitalist system had a lower risk of in-hospital mortality (OR: 0.91; 95% CI: 0.87–0.96). Specifically, patients in their 80s (OR = 0.31; 95% confidence interval [CI]: 0.19–0.52) and those with high CCI (OR = 0.93; 95% CI: 0.87–0.99) had a more significant association with lower in-hospital mortality.

Conclusions

Hospitalist services are associated with reduced in-hospital mortality rates in cancer patients, which may be influenced by continuous patient management and expertise. Our results highlight the need for dedicated personnel stationed in hospital wards for improved outcomes of patients with cancer. Our results may encourage the government to consider the expansion of the current policies for efficient allocation of healthcare resources among hospitals in Korea.

Abstract Image

住院医师制度的实施与癌症患者住院死亡率:基于国民健康保险队列数据。
导读:住院医师直接对住院病人负责,从住院到出院。最近,韩国开始对住院医生的服务进行报销。然而,缺乏证据表明医院与医疗质量的提高有关。我们调查了住院医师制度与降低癌症患者住院死亡率之间的关系。方法:这项以全国人群为基础的回顾性队列研究纳入了来自三级和综合医院的398,732名癌症患者,这些患者的住院医师数据来自2021年韩国国民健康保险服务队列数据库。获得住院死亡率数据,定义为入院和出院之间存在死亡记录。为了增加可比性,我们根据性别、年龄、医院类型、医院区域、查尔森合并症指数(CCI)和原发癌症类型进行了1:3倾向评分匹配。我们使用广义估计方程模型来估计住院死亡率的调整优势比(OR)。结果:住院医师制度下患者的院内死亡风险较低(OR: 0.91; 95% CI: 0.87-0.96)。具体而言,80多岁患者(OR = 0.31; 95%可信区间[CI]: 0.19-0.52)和高CCI患者(OR = 0.93; 95% CI: 0.87-0.99)与较低的住院死亡率有更显著的相关性。结论:住院医师服务与降低癌症患者住院死亡率相关,这可能受到持续的患者管理和专业知识的影响。我们的结果强调需要专门的人员驻扎在医院病房,以改善癌症患者的预后。我们的研究结果可能会鼓励政府考虑扩大韩国医院之间有效分配医疗资源的现行政策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信